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Foreword
TheBritishAssociation ofLungResearch(BALR)has
beeninexistencesomesevenyearsandenjoysahealthy
membership of some 200 individuals from academia,
governmentestablishments, industry, andmedical/clini-
cal units. Thegroup meetsthree orfourtimes annually
to address specific topics in the lung research field.
Eachyear, onemajortwo-daymeetingisheld. Because
thetopicaddressedhasacentralthemeandmuchofthe
workpresentedisnew, therehasbeenafeelingforsome
time withinthemembershipthattheproceedingsofthe
meeting should be published.
Thethemeofthemeetingchosenfor 1988wasChemi-
calsandLung 7bxicity, mainly because there hasbeen
considerable impetus in this field in the UK within the
last five years. Witschi, Smith, Cohen, and Hook were
invited to speak in view of their contribution to this
researcharea. Theywereaskedtoreviewaspectsoflung
tissue interaction with chemicals, the targeting of
chemicals to cells, and how compounds could be
biotransformed. Alsothey discussedthemechanisms of
biological damage and repair. These fourareas were ex-
panded on by the free communications solicited from
the other participants.
Lungsliceculturesaredescribedinthestudyofredox
cycling, asystemwithcompromisedantioxidantdefenses
and the toxicity of thiourea and various drugs. Both
Type II epithelial cells and Claracells represent sites of
chemicalbiotransformationbecauseoftheirhighactiv-
ity of cytochrome P-450 isozymes and their ability to
accumulate toxins. A new method is described in these
proceedings for the isolation of Clara cells from the
mouse, and a second paper deals with the culture of
thesecellsandasimple invitrotestusinganattachment
assay system ofNADPH-cytochrome (P-450)reductase-
positivecellstoexaminetheeffectsofbronchiolartoxins.
AmethodisalsodescribedtoobtainhumanType IIcells,
andthefirstevidencehasbeenprovidedthatlipocortin
1 (aglucocorticoid-inducible proteinthat mayreducein-
flammation) is present in human lung lavage.
Anumberofpresentations concentrate oninflamma-
tion and edema that are important primary events of
toxin-induced damage and their possible amelioration
with such agents as BN 52021, a receptor agonist for
platelet-activatingfactor, orN-acetylcysteine, afreeradi-
calscavenger. Severalstudiesemployedthesensoryirri-
tant and intermediary metabolite of a variety of
chemicals affecting the lung, namely, acrolein. Other
investigations describe the ability ofzinc chloride with
andwithout70% oxygenexposuretodamagelungtissue.
The mechanism ofquartz-induced lipoproteinosisisdis-
cussed, as is the manner in which chemically modified
amosite asbestos interacts with cell membranes.
Insummaryfromthe centralissuesofbiotransforma-
tion and mechanism ofaction of chemicals in the lung,
abroadbaseofstudiesweredevelopedthatIbelievewill
be of use to a number of investigators of lung damage
caused by chemicals and drugs. While it is true thatthe
majority ofthe individuals within this conference gave
emphasis to the toxicological aspects ofthe reaction of
chemicals with the lung, many could not have failed to
recognize the very thin dividing line between toxicity
and therapeutic advantage. It ishoped thatthe contin-
uingimprovementsinboththespecificcellulartargeting
of chemicals and an increase in the understanding of
their mechanism ofaction will provide the basis ofthe
future treatment of lung disorders.
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